Fingolimod

CAS 162359-55-9

About the API

Molecular Formula C19H33NO2
Molecular Weight 307.471 g/mol
Therapeutic category Antineoplastic & Immunomodul
Available formulations Oral Solid
Regulations Canada DMF Flag Canada DMF CEP Flag CEP EU DMF Flag EU DMF Other Flag Other US DMF Flag US DMF

General Information

Fingolimod is indicated for the treatment of patients aged 10 and above with relapsing forms of multiple sclerosis, which may include clinically isolated syndrome, relapsing-remitting disease, as well as active secondary progressive disease. It is used to prevent episodes of symptoms and slow the worsening of disability in patients with relapsing-remitting forms of multiple sclerosis. Fingolimod is in a class of medications called sphingosine l-phosphate receptor modulators. It works by decreasing the action of immune cells that may cause nerve damage.